Of note, two out of four PD-1 positive tumors bore a TP53 mutation, while one out of four bore a mutation in PIK3CA, which suggested that the mutations in these two cancer driver genes are not associated with PD-1 positivity. This evidence concerns the gene TP53 and cancer.